©The Author(s) 2025.
World J Gastrointest Surg. Nov 27, 2025; 17(11): 109989
Published online Nov 27, 2025. doi: 10.4240/wjgs.v17.i11.109989
Published online Nov 27, 2025. doi: 10.4240/wjgs.v17.i11.109989
Table 2 Conversion rates
| Ref. | Year | RLR conversion rate | LLR conversion rate | OLR conversion rate | Statistical comparison |
| Safiejko et al[6] | 2024 | 6.7% (NR) | 12.4% (NR) | NR | LLR vs RLR: OR = 2.18, 95%CI: 1.46-3.24 |
| Machairas et al[7] | 2021 | 0% (0/29) | NR | NR | NR |
| Mkabaah et al[9] | 2025 | 4.7% (10/214) | 10.4% (328/3166) | NR | LLR vs RLR: OR = 27.50, 95%CI: 7.73-97.48 |
| Ho et al[12]1 | 2013 | 4.6% (10/217) | NR | NR | NR |
| McGuirk et al[13] | 2021 | 0% (0/28) | NR | NR | NR |
- Citation: Ardila CM, Zuluaga-Gómez M, González-Arroyave D. Robotic liver surgery for metastatic disease: A review of safety, feasibility, and outcomes. World J Gastrointest Surg 2025; 17(11): 109989
- URL: https://www.wjgnet.com/1948-9366/full/v17/i11/109989.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i11.109989